SunGen Pharma Receives Sixth ANDA Approval from US FDA

PRINCETON, N.J., Jul. 8 (Korea Bizwire) — SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its sixth ANDA approval from the US Food and Drug Administration (FDA). The sixth approved ANDA is for Methylprednisolone tablets, 4 mg. This drug product is [...]